Ubiquitin-specific protease 14 expression associated with intrahepatic cholangiocarcinoma cell differentiation

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 3, 2011, Pages 775-779

  Chuensumran, Ubol ^a   Saelee, Pensri ^b   Punyarit, Phaibul ^c   Wongkham, Sopit ^d   Pairojkul, Chawalit ^d   Chauin, Siri ^d   Petmitr, Songsak ^e  

^a SUAN DUSIT UNIVERSITY   (Thailand)

^b NATIONAL CANCER INSTITUTE   (Thailand)

^c PHRAMONGKUTKLAO HOSPITAL   (Thailand)

^d KHON KAEN UNIVERSITY   (Thailand)

^e MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Cell differentiation; Intrahepatic cholangiocarcinoma; Ubiquitin specific protease 14

Indexed keywords

EID: 79958798500     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bodin L, Beaune PH, Loriot MA.(2005) Determination of cytochrome P450 2D6 (CYP2D6) gene copy number by real-time quantitative PCR. J Biomed Biotechnol, 3, 248-53.
2. Chariyalertsak S, Khuhaprema T, Bhudisawasdi V, et al.(2005). Novel DNA amplification on chromosomes 2p25.3 and 7q11.23 in cholangiocarcinoma identified by arbitrarily primed polymerase chain reaction. J Cancer Res Clin Oncol, 131, 821-28.
3. Chuensumran U, Wongkham S, Pairojkul C, et al.(2007). Prognostic value of DNA alterations on chromosome 17p13.2 for intrahepatic cholangiocarcinoma. World J Gastroenterol, 13, 2986-91.
4. Chung KK, Dawson VL, Dawson TM.(2001). The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders. Trends Neurosci, 24, S7-14.
5. Haswell-Elkins MR, Satarug S, Elkins DB.(1992). Opisthorchis viverrini infection in northeast Thailand and its relationship to cholangiocarcinoma. J Gastroenterol Hepatol, 7, 538-48.
6. Honda R, Tanaka H, Yasuda H.(1997). Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett, 420, 25-7.
7. IARC Working Group.(1994). IARC Monographs on the evaluation of carcinogenic risks to humans. In: Infection with liver flukes (Opisthorchis viverrini, Opisthorchis felineus, and Clonorchis sinensis). IARC, Lyon, 61, 121-75.
8. Lee BH, Lee MJ, Park S, et al.(2010). Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature, 467, 179-4.
9. Livak KJ, Schmittgen TD.(2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-8.
10. Navarro JM, Jorcano JL.(1999). The use of arbitrarily primed polymerase chain reaction in cancer research. Electrophoresis, 20, 283-0.
11. Parkin DM, Ohshima H, Srivatanakul P, et al.(1993). Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. Cancer Epidemiol Biomarkers Prev, 2, 537-44.
12. Pongstaporn W, Rochanawutanon M, Wilailak S, et al.(2006). Genetic alterations in chromosome 10q24.3 and glutathione S-transferase omega 2 gene polymorphism in ovarian cancer. J Exp Clin Cancer Res, 25, 107-14.
13. Prior FA, Tackaberry ES, Aubin RA, et al.(2006). Accurate determination of zygosity in transgenic rice by real-time PCR does not require standard curves or efficiency correction. Transgenic Res, 15, 261-5.
14. Puente XS, Sánchez LM, Overall CM, et al.(2003). Human and mouse proteases: a comparative genomic approach. Nat Rev Genet, , 544-58.
15. Schwartz AL, Ciechanover A.(1999). The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annu Rev Med, 50, 57-4.
16. Shaib YH, Davila JA, McGlynn K, et al.(2004). Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol, 40, 472-7.
17. Shimonishi T, Sasaki M, Nakanuma Y.(2000). Precancerous lesions of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat urg, 7, 542-50.
18. Shinji S, Naito Z, Ishiwata S, et al.(2006). Ubiquitin-specific protease 14 expression in colorectal cancer is associated with liver and lymph node metastases. Oncol Rep, 15, 539-43.
19. Singh KP, Roy D.(2006). SKCG-1: a new candidate growth regulatory gene at chromosome 11q23.2 in human sporadic Wilms tumours. Br J Cancer, 94,1524-32.
20. Srivatanakul P, Ohshima H, Khlat M, et al.(1991). Opisthorchis viverrini infestation and endogenous nitrosamines as risk factors for cholangiocarcinoma in Thailand. Int J Cancer, 48, 821-5.
21. Ventii KH, Wilkinson KD.(2008). Protein partners of deubiquitinating enzymes. Biochem J, 414, 161-75.
22. Wada T, Yamashita Y, Saga Y, et al.(2009). Screening for genetic abnormalities involved in ovarian carcinogenesis using retroviral expression libraries. Int J Oncol, 35, 973-6.
23. Watanapa P, Watanapa WB.(2002). Liver fluke-associated cholangiocarcinoma. Br J Surg, 89, 962-70.
24. Watanapa P.(1996). Cholangiocarcinoma in patients with opisthorchiasis. Br J Surg, 83, 1062-4.
25. Welsh J, McClelland M.(1990). Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Res, 18, 7213-18.
26. Williams JG, Kubelik AR, Livak KJ, et al.(1990). DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nucleic Acids Res, 18, 6531-5.